Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 04/26
2344 INR   -0.17%
04/25GLAXO : 1Q Earnings Snapshot
AQ
03/28Company strikes £9.2 billion deal
AQ
03/23Glaxo in pole position in race for £14bn rival
AQ
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
04/20/2018 04/23/2018 04/24/2018 04/25/2018 04/26/2018 Date
2417.95(c) 2405(c) 2378(c) 2348(c) 2344(c) Last
13 770 7 848 8 291 6 403 8 078 Volume
+1.59% -0.54% -1.12% -1.26% -0.17% Change
More quotes
Financials (INR)
Sales 2018 30 655 M
EBIT 2018 4 676 M
Net income 2018 3 653 M
Finance 2018 6 371 M
Yield 2018 1,93%
Sales 2019 34 406 M
EBIT 2019 5 705 M
Net income 2019 4 374 M
Finance 2019 7 826 M
Yield 2019 2,14%
P/E ratio 2018 54,83
P/E ratio 2019 47,09
EV / Sales2018 6,29x
EV / Sales2019 5,56x
Capitalization 199 B
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
05/24Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
04/25GLAXO : 1Q Earnings Snapshot
AQ
03/30FE 1000 : Rankings by market cap - glaxosmithkline pharmaceuticals lim..
AQ
03/28Company strikes £9.2 billion deal
AQ
03/27FE1000-INDIA'S FINEST COMPANIES 2017 : Rankings by net revenue - glaxosmithklin..
AQ
03/25GLAXOSMITHKLINE PHARMACEUTICALS : Trailing twelve month results - glaxosmithklin..
AQ
03/24GLAXOSMITHKLINE PHARMACEUTICALS : Quarterly results - glaxosmithkline pharmaceut..
AQ
03/23Glaxo in pole position in race for £14bn rival
AQ
03/22Glaxo in pole as Reckitt bails on Pfizer deal
AQ
03/14GLAXOSMITHKLINE : Glaxo chief's £4.9m payday
AQ
03/06Glaxo's Encouraging Asthma & HIV Data at Medical Meetings
AQ
More news
Sector news : Pharmaceuticals - NEC
09:00aSANOFI : Sales, Net Income Fall in 1Q; Plans Share Buyback -- Update
DJ
08:39aSANOFI : Correction to Sanofi Article on 1Q Results
DJ
08:29aSanofi first-quarter hit by exchange rates, diabetes, growth not seen before ..
RE
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
08:13aSANOFI : Sales, Income Fell in 1Q; Plans Share Buyback
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/05God bless Deepak Parekh who has managed to shield the HDFC twins from Govt. s..
8
03/13HDFC AMC, the mutual fund arm of Deepak Parekh promoted HDFC will soon make i..
1
02/21Thanks for a great lunch at the iconic Birla House, adjoining Gandhi Smriti. ..
1263
02/20#NPAs Will Increase Due To #PNBFraud Case: Deepak Parekh :  
02/19'Need more regular audits in banks to ensure frauds are detected,' says HDFC ..
9
More tweets
Qtime:35
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE PHARMACEUT
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 2 304  INR
Spread / Average Target -1,3%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Puja Thakur Chief Financial Officer
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-6.08%2 986
JOHNSON & JOHNSON-9.68%338 522
PFIZER2.32%220 455
NOVARTIS-8.69%202 567
ROCHE HOLDING LTD.-11.66%193 904
MERCK AND COMPANY5.97%161 967